GlobeNewswire Inc | Jul 13, 2021 08:00AM EDT

July 13, 2021

SEATTLE, July 13, 2021 (GLOBE NEWSWIRE) -- Nautilus Biotechnology, Inc. (NASDAQ: NAUT; or Nautilus), a company pioneering a single-molecule protein analysis platform for quantifying the proteome,today announced it will report financial results for the second quarter of fiscal year 2021 before market open on Tuesday, August 10th, 2021.

The companys management will webcast a corresponding conference call beginning at 5:00 a.m. Pacific Time / 8:00 a.m. Eastern Time to discuss its results, business developments, and outlook. Live audio of the webcast will be available on the Investors section of the company website at: www.nautilus.bio.

About Nautilus Biotechnology, Inc.

Based in Seattle, Washington, Nautilus is a development stage life sciences company creating a platform technology for quantifying and unlocking the complexity of the proteome. Nautilus mission is to transform the field of proteomics by democratizing access to the proteome and enabling fundamental advancements across human health and medicine. To learn more about Nautilus, visit www.nautilus.bio

Contacts

Investors:InvestorRelations@nautilus.bio

Media:Thermal for Nautilus BiotechnologyKaustuva DasPress@nautilus.bio